Literature DB >> 35266091

Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction.

Yong Wang1, Juan Zhang1,2, Zhen Wang1, Cheng Wang3, Dufang Ma4.   

Abstract

Although the prevalence of heart failure with preserved ejection fraction (HFpEF) is growing worldwide, its complex pathophysiology has yet to be fully elucidated, and multiple hypotheses have all failed to produce a viable target for therapeutic action or provide effective treatment. Cardiac remodeling has long been considered an important mechanism of HFpEF. Strong evidence has been reported over the past years that coronary microvascular dysfunction (CMD), manifesting as structural and functional abnormalities of coronary microvasculature, also contributes to the evolution of HFpEF. However, the mechanisms of CMD are still not well understood and need to be studied further. Coronary microvascular endothelial cells (CMECs) are one of the most abundant cell types in the heart by number and active players in cardiac physiology and pathology. CMECs are not only important cellular mediators of cardiac vascularization but also play an important role in disease pathophysiology by participating in the inception and progression of cardiac remodeling. CMECs are also actively involved in the pathogenesis of CMD. Numerous studies have confirmed that CMD is closely related to cardiac remodeling. ECs may serve a critical function in mediating the connection between CMD and HFpEF. It follows that CMECs participate in the mechanism of CMD leading to HFpEF. In this review article, we focus on the role of CMD in the pathogenesis of HFpEF resulting from cardiac remodeling and highlight the subsequent complexity of the EC-mediated correlation between CMD and HFpEF.
© 2022. The Author(s).

Entities:  

Keywords:  Coronary microvascular dysfunction; Endothelial cell; Heart failure with preserved ejection fraction

Year:  2022        PMID: 35266091     DOI: 10.1007/s10741-022-10224-y

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  72 in total

1.  Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.

Authors:  Kathryn Dryer; Mark Gajjar; Nikhil Narang; Margaret Lee; Jonathan Paul; Atman P Shah; Sandeep Nathan; Javed Butler; Charles J Davidson; William F Fearon; Sanjiv J Shah; John E A Blair
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-09       Impact factor: 4.733

Review 2.  Pathophysiology of heart failure.

Authors:  Robert H G Schwinger
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

Review 3.  Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.

Authors:  Andrew Xanthopoulos; Filippos Triposkiadis; Randall C Starling
Journal:  Trends Cardiovasc Med       Date:  2018-01-09       Impact factor: 6.677

4.  Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.

Authors:  Viviany R Taqueti; Scott D Solomon; Amil M Shah; Akshay S Desai; John D Groarke; Michael T Osborne; Jon Hainer; Courtney F Bibbo; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2018-03-07       Impact factor: 29.983

Review 5.  Coronary Microvascular Dysfunction - Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy.

Authors:  Cheng Chen; Janet Wei; Ahmed AlBadri; Parham Zarrini; C Noel Bairey Merz
Journal:  Circ J       Date:  2016-11-29       Impact factor: 2.993

6.  Coronary microvascular dysfunction in hypertrophy and heart failure.

Authors:  Paolo G Camici; Carsten Tschöpe; Marcelo F Di Carli; Ornella Rimoldi; Sophie Van Linthout
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

Review 7.  Coronary microvascular dysfunction in diabetes mellitus.

Authors:  Aleksandar Kibel; Kristina Selthofer-Relatic; Ines Drenjancevic; Tatjana Bacun; Ivica Bosnjak; Dijana Kibel; Mario Gros
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

8.  Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.

Authors:  Sanjiv J Shah; Carolyn S P Lam; Sara Svedlund; Antti Saraste; Camilla Hage; Ru-San Tan; Lauren Beussink-Nelson; Ulrika Ljung Faxén; Maria Lagerström Fermer; Malin A Broberg; Li-Ming Gan; Lars H Lund
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

Review 9.  Microcirculation and Heart Failure.

Authors:  Davor Miličić; Nina Jakuš; Dora Fabijanović
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 10.  Highlights in heart failure.

Authors:  Daniela Tomasoni; Marianna Adamo; Carlo Mario Lombardi; Marco Metra
Journal:  ESC Heart Fail       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.